-
Usher in the growth turning point, seize the opportunity of The Times - Chairman Shi Yuanyuan made a keynote report at the group's general meeting of staffIn order to thoroughly implement the future work deployment of Shenzhen Cell Valley and its subsidiaries, clarify work objectives, gather development consen...02-11 -
Jointly promote TCR-T cell therapy based on retrovirus vector - Professor Li Liangping, Chairman of Tesai Immunity, and his team visited Shenzhen Cell Valley for exchangeOn October 31, Professor Li Liangping, chairman and founder of Tesai Immunization (Guangzhou) Technology Co., Ltd. and his team visited Shenzhen Cell Valley...02-11 -
Beijing Daxing District leaders visit Shenzhen Cell ValleyOn October 24, CAI Xiaojun, Standing Committee of Beijing Daxing District Party Committee and United Front Minister, Zheng Qingyu, Deputy Minister of the Unit...02-11 -
Our chairman Shi Yuanyuan and chief scientist Wang Jianxun were selected as expert members of the uation Committee of senior professional titles of light industry Engineering in Shenzhen (personalizedRecently, our chairman Shi Yuanyuan and chief scientist Wang Jianxun were selected as expert members of the Shenzhen Municipal Light Industry Engineering Se...02-11 -
Final sprint - Shenzhen Cell Valley successfully held the Ministry of Science and Technology national key research and development plan project application seminarRecently received the notice of the Ministry of Science and Technology, after several months of pre-declaration, letter review, and formal declaration of the ...02-11 -
Shenzhen Cell Valley won the bid for the procurement project of "GMP grade CAR T cell preparation" from Huazhong University of Science and Technology Union Shenzhen HospitalOn the afternoon of October 11, Shenzhen Cell Valley Biomedicine Co., Ltd. won the bid for the "GMP grade CAR T cell preparation" project in Huazhong ...02-11
